Third-Party Tested by Verum Analytics
Selank
Synthetic behavioural-research peptide derived from tuftsin, researched for cognitive and immunomodulatory effects.
Third-Party Tested by Verum Analytics
Albert's Verdict
Selank's anxiolytic profile without sedation is what makes it stand out in the cognitive category. The BDNF upregulation data suggests it's doing more than modulating GABA — there's a genuine neuroprotective signal worth studying.
View COA✓ In stock - Ships same day
Arrives as lyophilized (powder) form
Shipped freeze-dried for maximum stability and shelf life. See laboratory preparation guide for handling instructions.
Product Description
Selank is a synthetic heptapeptide developed by combining the tuftsin sequence (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro C-terminal tripeptide. Like Semax, it was developed at the Institute of Molecular Genetics in Russia and has been extensively studied for its behavioural-research and nootropic properties.
Research indicates Selank may modulate the expression of brain-derived neurotrophic factor (BDNF) and influence GABAergic neurotransmission without causing sedation or dependence commonly associated with traditional behavioural-research. Studies have examined its potential effects on behavioural research models, cognitive-pathway research, and immune-pathway research function.
Selank has also been investigated for its immunomodulatory properties, with research suggesting it may influence cytokine balance and immune cell activity. Its dual action on both neurological and immunological systems makes it a unique research compound.
Frequently Researched Together
Commonly studied alongside in laboratory settings
Learn More About This Peptide
Research Use Only: This product is intended for laboratory research purposes only. Not for human consumption.